Showing posts with label Precision Medicine industry trend. Show all posts
Showing posts with label Precision Medicine industry trend. Show all posts

Wednesday, 18 April 2018

Precision Medicine Market in depth study and analysis published, 2022

Summary
The advancement and innovation of new healthcare technologies are developing the platform for the growth of precision medicine market. Since, the announcement of ‘Precision Medicine Initiative’ by the president Barack Obama in January end, 2015, a  large number of research and developments are being done for the development of precise drugs, targeted therapeutics,  and laboratory tests. Presently, the main focus of the government initiatives is toward oncology, but it is anticipated to target almost all therapeutic area affected by genetic mutations.
The global precision medicine market is expected to reach $ 88 billion by 2022 at a CAGR of 12.0% during the forecast period.   
On the basis of sub-markets, Pharmacogenomics is by far the fastest growing segment of global precision medicine market and it is expected to reach $12.0 billion by 2022.
Click here for sample report @ http://www.wiseguyreports.com/sample-request/826425-global-precision-medicine-market-estimate-and-forecast-through-2015-2022
Key Players
The leading market players in the global precision medicine market include; Abbott Laboratories (U.S), Almac Group, Ltd. (U.K.), ASURAGEN, Inc. (U.S.), bioMérieux SA (France), Cepheid Inc. (U.S.), GE Healthcare (U.S), GlaxoSmithKline Plc (GSK) (U.K.), Johnson & Johnson (U.S) Medtronic (U.S.) and others.
Key Findings
•    Americas dominated the global precision medicine market in 2015; however, it is expected to grow at a CAGR of 11.6% during 2015 – 2022.
•    The companion diagnostics segment holds the largest share, with $10 billion value of the total market in 2015; while it is expected to reach $21.3 billion in 2022, at a CAGR of 13.4% for the period 2015-2022.
•    The cancer segments hold the largest share, with $21.1 billion value, of the total market in 2015; while it is expected to reach $46.3 billion in 2022, at a CAGR of 11.8% for the period 2015 – 2022.
•    Abbott Laboratories (U.S), GlaxoSmithKline Plc (GSK) (U.K.), Johnson & Johnson (U.S) Medtronic (U.S.), are so far the leading market players for precision medicine market globally  
 Table of Contents 
1 REPORT SCOPE 26
1.1 SCOPE OF THE STUDY 26
1.2 PRECISION MEDICINE: REPORT COVERAGE 27
1.3 RESEARCH METHODOLOGY 29
1.3.1 RESEARCH METHODOLOGY FOR THE GLOBAL MARKET STUDY 30
1.3.1.1 Geographical Analysis 30
1.3.1.2 Demand Side & Supply Side Analysis 31
1.3.1.3 Data Synthesis and Bridging 31
1.3.2 GLOBAL PRECISION MEDICINE: RESEARCH METHODOLOGY 32
1.3.3 KEY DATA POINT SOURCES 33
1.3.3.1 Data Points taken from Secondary Sources 33
1.3.3.2 Data Points taken from Primary Sources 33
1.4 REPORT DESCRIPTION 34
2 EXECUTIVE SUMMARY 38
3 MARKET OVERVIEW 42
3.1 INTRODUCTION 42
3.2 MARKET TIMELINE 42
3.3 KEY PARTICIPANTS, STRATEGIES & DEVELOPMENTS 50
3.3.1 GOVERNMENT AGENCIES 50
3.3.2 ACADEMIC INSTITUTIONS 50
3.3.3 DEVICE & SERVICE PROVIDERS 51 
 .Continued
For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/826425-global-precision-medicine-market-estimate-and-forecast-through-2015-2022
About Us
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.
Contact Us:
NORAH TRENT
Partner Relations & Marketing Manager
sales@wiseguyreports.com
www.wiseguyreports.com
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)